Cargando…
Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect
Viral haemorrhagic fever—VHF—virus and a number of other special viruses are considered to cause the world’s most dangerous infections with very high mortality, lack of therapeutic possibilities and often absence of effective vaccines. Such viruses are identified as “biohazard-level 4” agents and ar...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120164/ http://dx.doi.org/10.1007/978-3-319-99921-0_88 |
_version_ | 1783514915713056768 |
---|---|
author | Andersen, Bjørg Marit |
author_facet | Andersen, Bjørg Marit |
author_sort | Andersen, Bjørg Marit |
collection | PubMed |
description | Viral haemorrhagic fever—VHF—virus and a number of other special viruses are considered to cause the world’s most dangerous infections with very high mortality, lack of therapeutic possibilities and often absence of effective vaccines. Such viruses are identified as “biohazard-level 4” agents and are treated at the highest level of infection protection with strict isolation measures. At least 14 patients with Ebola disease were transported to Europe and the United States (11 patients) for hospital treatment during the African epidemic in 2014. There were no secondary spread of VHF import cases in Europe and the United States from 1999 until the Ebola outbreak in 2014. Then there were three cases of nosocomial spread to personnel in hospitals, two in the United States and one in Spain, despite alleged use of strict containment routines. This indicates a high risk of spread of infection through intensive treatment and handling of very sick persons with VHF like Ebola. In most cases vaccines are not available or specific antiviral drugs. Therefore, infection control must be based on a proper infection protection. This chapter is focused on practical means to handle and treat patients with suspect VHF or other dangerous agents to avoid spread to personnel and environment |
format | Online Article Text |
id | pubmed-7120164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71201642020-04-06 Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect Andersen, Bjørg Marit Prevention and Control of Infections in Hospitals Article Viral haemorrhagic fever—VHF—virus and a number of other special viruses are considered to cause the world’s most dangerous infections with very high mortality, lack of therapeutic possibilities and often absence of effective vaccines. Such viruses are identified as “biohazard-level 4” agents and are treated at the highest level of infection protection with strict isolation measures. At least 14 patients with Ebola disease were transported to Europe and the United States (11 patients) for hospital treatment during the African epidemic in 2014. There were no secondary spread of VHF import cases in Europe and the United States from 1999 until the Ebola outbreak in 2014. Then there were three cases of nosocomial spread to personnel in hospitals, two in the United States and one in Spain, despite alleged use of strict containment routines. This indicates a high risk of spread of infection through intensive treatment and handling of very sick persons with VHF like Ebola. In most cases vaccines are not available or specific antiviral drugs. Therefore, infection control must be based on a proper infection protection. This chapter is focused on practical means to handle and treat patients with suspect VHF or other dangerous agents to avoid spread to personnel and environment 2018-09-25 /pmc/articles/PMC7120164/ http://dx.doi.org/10.1007/978-3-319-99921-0_88 Text en © Springer Nature Switzerland AG 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Andersen, Bjørg Marit Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title | Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title_full | Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title_fullStr | Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title_full_unstemmed | Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title_short | Viral Haemorrhagic Fever (VHF) and Other Serious Viral Infections: First contact - how to act and protect |
title_sort | viral haemorrhagic fever (vhf) and other serious viral infections: first contact - how to act and protect |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120164/ http://dx.doi.org/10.1007/978-3-319-99921-0_88 |
work_keys_str_mv | AT andersenbjørgmarit viralhaemorrhagicfevervhfandotherseriousviralinfectionsfirstcontacthowtoactandprotect |